Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

CityU biologists discover super-enhancers that switch on breast cancer genes

Super-enhancers complexes zoom in transcription in cancer, Journal of Experimental & Clinical Cancer Research

Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. - Abstract - Europe PMC

Frontiers Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

IJMS, Free Full-Text

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

Decoding gene regulatory circuitry underlying TNBC chemoresistance reveals biomarkers for therapy response and therapeutic targets

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia, Journal of Experimental & Clinical Cancer Research

IJMS, Free Full-Text

Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets